Nomura Holdings Inc. ADR [NMR] stock prices are up 1.27% to $6.37 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The NMR shares have gain 4.08% over the last week, with a monthly amount glided 9.83%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On January 25, 2024, upgrade upgraded it’s rating to Buy. Jefferies downgraded its rating to a Hold. Goldman downgraded its rating to a Neutral. JP Morgan downgraded its rating to Underweight for this stock on March 29, 2021. In a note dated March 09, 2021, Goldman upgraded an Buy rating on this stock.
The stock price of Nomura Holdings Inc. ADR [NMR] has been fluctuating between $4.66 and $6.62 over the past year. Currently, Wall Street analysts expect the stock to reach $5.79 within the next 12 months. Nomura Holdings Inc. ADR [NYSE: NMR] shares were valued at $6.37 at the most recent close of the market. An investor can expect a potential drop of -9.11% based on the average NMR price forecast.
Analyzing the NMR fundamentals
The Nomura Holdings Inc. ADR [NYSE:NMR] reported sales of 31.33B for trailing twelve months, representing a surge of 18.76%. Gross Profit Margin for this corporation currently stands at 0.22% with Operating Profit Margin at 0.1%, Pretax Profit Margin comes in at 0.1%, and Net Profit Margin reading is 0.07%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.08 and Total Capital is 0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of4.35.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.27 points at the first support level, and at 6.17 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.46, and for the 2nd resistance point, it is at 6.56.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 0.60, the price to book ratio is 0.82 and price to earnings (TTM) ratio is 10.80.
